Discover the revival of the biotech sector, with IPOs resurging and promising weight loss drug potential, despite facing ...

The U.S. IPO market looks to be gathering steam, with a few names springing up that are attracting investor attention.

The Swiss pharma is paying Regor Therapeutics $850 million to buy a pair of prospects it sees as potential successors to blockbuster medicines from Pfizer and Eli Lilly.

Among the investors in Aktis’ Series B round were Bristol Myers Squibb, Eli Lilly and Merck & Co., all of which have expanded their involvement in the radiopharma field.

Nano Labs shares are trading lower by around 55% during Thursday's session. The company announced the pricing of a $5 million registered direct offering. Henry Khederian Why Ascent Solar ...

Laurus Labs is a science-led fully integrated pharmaceutical and biotechnology manufacturing company with a leadership position in generic active pharmaceutical ingredients (APIs) in selected ...

The man charged with attempting to assassinate Donald Trump after allegedly positioning himself with a rifle outside one of the former president's Florida golf courses on Sept. 15 pleaded not ...

ASHEVILLE, North Carolina — Widespread devastation left behind by Hurricane Helene came into light Monday across the South, revealing a wasteland of splintered houses, crushed cargo containers ...

Morepen Laboratories Ltd., incorporated in the year 1984, is a Small Cap company (having a market cap of Rs 4,756.79 Crore) operating in Pharmaceuticals sector. Morepen Laboratories Ltd. key ...

Ind-Swift Laboratories Ltd., incorporated in the year 1995, is a Small Cap company (having a market cap of Rs 776.16 Crore) operating in Pharmaceuticals sector. Ind-Swift Laboratories Ltd. key ...

Copyright 2024 The Associated Press. All Rights Reserved. People across the American Southeast stay resilient in the wake of Hurricane Helene Americans in the ...